Liquid Mind

LiquidMind is an artificial intelligence-driven biotechnology company dedicated to building foundation models for drug discovery and development. Founded by Nima Alidoust, the former CEO of VantAI, the company leverages generative AI to navigate and optimize complex chemical and biological spaces. LiquidMind's platform is designed to accelerate the identification of novel therapeutic candidates by providing high-fidelity predictions and innovative molecular designs. The company operates at the intersection of deep learning and structural biology to address challenging drug targets that have historically been difficult to prosecute. LiquidMind aims to partner with pharmaceutical organizations to streamline the transition from target identification to the delivery of clinical-ready candidates.